|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2011-4-11
|
|
pubmed:abstractText |
Changes in the copy number of chromosomal DNA segments [copy number variants (CNVs)] have been implicated in human variation, heritable diseases and cancers. Microarray-based platforms are the current established technology of choice for studies reporting these discoveries and constitute the benchmark against which emergent sequence-based approaches will be evaluated. Research that depends on CNV analysis is rapidly increasing, and systematic platform assessments that distinguish strengths and weaknesses are needed to guide informed choice.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1367-4811
|
|
pubmed:author |
pubmed-author:BaylinSteveS,
pubmed-author:CarvalhoBeniltonB,
pubmed-author:DohenyKimK,
pubmed-author:DziedzicAmandaA,
pubmed-author:FrelinLaurenceL,
pubmed-author:Halper-StrombergEitanE,
pubmed-author:HaoHaipingH,
pubmed-author:HetrickKurtK,
pubmed-author:IrizarryRafael ARA,
pubmed-author:JedlickaAnneA,
pubmed-author:JieChunfaC,
pubmed-author:PevsnerJonathanJ,
pubmed-author:RuczinskiIngoI,
pubmed-author:ScharpfRobertR,
pubmed-author:ScottAlan FAF,
pubmed-author:SpencerForrestF
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
15
|
|
pubmed:volume |
27
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1052-60
|
|
pubmed:meshHeading |
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Performance assessment of copy number microarray platforms using a spike-in experiment.
|
|
pubmed:affiliation |
Department of Biostatistics, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Evaluation Studies,
Research Support, N.I.H., Extramural
|
